Deutsch English Français

Contact

EP1194173

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1194173

EP1194173 - X-RAY GUIDED DRUG DELIVERY [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 08.05.2009 Database last updated on 15.06.2024
Most recent event Tooltip	08.05.2009	Application deemed to be withdrawn	published on 10.06.2009 [2009/24]
Applicant(s)	For all designated states VANDERBILT UNIVERSITY Office of Technology Transfer Suite 210 1207 17th Avenue South Nashville, TN 37212 / US
	[N/P]
Former [2002/15]	For all designated states Vanderbilt University Office of Technology Transfer, Suite 210, 1207 17th Avenue South Nashville, TN 37212 / US
Inventor(s)	01 / HALLAHAN, Dennis, E. 4214 Estes Road Nashville, TN 37215 / US
	[2002/15]
Representative(s)	Behnisch, Werner ATTENTION: ADDRESS INACTIVE - USE ASS-NR - CDR / DE
	[N/P]
Former [2008/33]	Behnisch, Werner Reinhard-Skuhra-Weise & Partner GbR Patentanwälte Friedrichstrasse 31 80801 München / DE
Former [2002/15]	Behnisch, Werner, Dr. Reinhard-Skuhra-Weise & Partner, Patentanwälte, Postfach 44 01 51 80750 München / DE
Application number, filing date	00935839.1	28.04.2000
	[2002/15]
	WO2000US11485
Priority number, date	US19990302456	29.04.1999 Original published format: US 302456
	[2002/15]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO0066182
	Date:	09.11.2000
	Language:	EN
	[2000/45]
	Type:	A1 Application with search report
	No.:	EP1194173
	Date:	10.04.2002
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 09.11.2000 takes the place of the publication of the European patent application.
	[2002/15]
Search report(s)	International search report - published on:	US	09.11.2000
	(Supplementary) European search report - dispatched on:	EP	31.03.2003
Classification	IPC:	A61K51/00, A61K49/00, A01N63/00, C12Q1/68, C12N15/85, C12N15/63, C07H21/04, A61K51/12, A61K41/00	[2003/20]
	CPC:	A61K41/0038 (EP,US); A61K51/1203 (EP,US); A61P35/00 (EP); A61P35/04 (EP); A61P43/00 (EP); A61P9/00 (EP)
	Former IPC [2002/15]	A61K51/00, A61K49/00, A01N63/00, C12Q1/68, C12N15/85, C12N15/63, C07H21/04
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2002/15]
Title	German:	ROENTGENSTRAHLENGESTEUERTE ARZNEIMITTELFREIGABE	[2002/15]
	English:	X-RAY GUIDED DRUG DELIVERY	[2002/15]
	French:	ADMINISTRATION DE MEDICAMENT GUIDEE PAR RAYON X	[2002/15]
Entry into regional phase	29.11.2001	National basic fee paid
	29.11.2001	Search fee paid
	29.11.2001	Designation fee(s) paid
	29.11.2001	Examination fee paid
Examination procedure	14.11.2000	Request for preliminary examination filed International Preliminary Examining Authority: US
	29.11.2001	Amendment by applicant (claims and/or description)
	29.11.2001	Examination requested [2002/15]
	28.02.2005	Despatch of a communication from the examining division (Time limit: M06)
	09.09.2005	Reply to a communication from the examining division
	13.08.2008	Despatch of a communication from the examining division (Time limit: M04)
	29.12.2008	Application deemed to be withdrawn, date of legal effect [2009/24]
	27.01.2009	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2009/24]
Fees paid	Renewal fee
	30.04.2002	Renewal fee patent year 03
	30.04.2003	Renewal fee patent year 04
	30.04.2004	Renewal fee patent year 05
	28.04.2005	Renewal fee patent year 06
	02.05.2006	Renewal fee patent year 07
	30.04.2007	Renewal fee patent year 08
	31.03.2008	Renewal fee patent year 09
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]WO9625947 (ARCH DEV CORP [US], et al) [X] 1-38 * the whole document *;
		[X]US5093104 (KAMINSKY DEBORAH [US]) [X] 1-38 * the whole document *;
		[X]EP0229718 (AMERSHAM INT PLC [GB]) [X] 1-38 * the whole document *;
		[X]US4619823 (YOKOYAMA AKIRA [JP], et al) [X] 1-38 * the whole document *;
		[X]DE2621311 (ABRAMOVICI J [BE], et al) [X] 1-38 * the whole document *;
		[X]WO9306835 (DANA FARBER CANCER INST INC [US]) [X] 1-38 * the whole document *;
		[X]WO9533496 (DIATECH INC [US]) [X] 1-38 * the whole document *;
		[X]WO8605693 (SCRIPPS CLINIC RES [US]) [X] 1-38 * the whole document *;
		[X]WO9612956 (WATSON CLINIC FOUNDATION [US]) [X] 1-38 * the whole document *;
		[X]WO9320229 (GENENTECH INC [US], et al) [X] 1-38 * the whole document *
	International search	[X]US5292524 (MALE ROXANNE [US], et al);
		[X]US5693627 (SCHIEVEN GARY L [US]);
		[Y]US5759542 (GUREWICH VICTOR [US]);
		[Y]US5334369 (HALUSHKA PERRY V [US], et al);
		[X] - BENDER ET AL., "Enhancement of monoclonal antibody efficacy: The effect of external beam radiation", HYBRIDOMA,, (199502), vol. 14, no. 2, pages 129 - 134, XP002932028
		[X] - BENDER ET AL., "External beam radiation enhances antibody mediated radiocytotoxicity in humans cells in vitro", ANTICANCER RESEARCH,, (199703), vol. 17, pages 1797 - 1802, XP002932029
		[X] - WEICHSELBAUM ET AL., "Gene therapy targeted by radiation preferentially radiosensitizes tumor cells", CANCER RESEARCH,, (19940815), vol. 54, pages 4266 - 4269, XP002932030
		[Y] - ROSENBERG ET AL., "Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays", JOURNAL OF THE NATIONAL CANCER INSTITUTE,, (197402), vol. 52, no. 2, pages 345 - 352, XP002932031
		[Y] - SONG ET AL., "Combined cytolytic effect of X irradiation and cell-mediated immune reactions on tumor cells in vitro", RADIOLOGY,, (197401), vol. 111, pages 213 - 214, XP002932032
		[Y] - STRATTON ET AL., "Imaging arterial thrombosis: Comparison of technetium-99m-labeled monoclonal antifibrin antibodies and indium-111-platelets", J. NUCL. MED.,, (1994), vol. 35, pages 1731 - 1737, XP002932033
		[Y] - HIRATA ET AL., "Fate of intravenously injected human tumor cells in the lung of nude mice following whole-body X-irradiation", INVASION METASTASIS,, (198501), vol. 5, pages 61 - 70, XP002932034
		[Y] - HIRATA ET AL., "Artificial metastases and decrease of fibrinolysis in the nude mouse lung after hemithoracic irradiation", CLINICAL EXPERIMENTAL METASTASIS,, (198404), vol. 2, no. 4, pages 311 - 319, XP002932035 DOI: http://dx.doi.org/10.1007/BF00135170
		[Y] - HALLAHAN ET AL., "E-selectin gene induction by ionizing radiation is independent of cytokine induction", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS,, (19951226), vol. 217, no. 3, pages 784 - 795, XP002932036 DOI: http://dx.doi.org/10.1006/bbrc.1995.2841

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p